G32.0
Subacute combined degeneration of spinal cord in diseases classified elsewhere
Clinical Classification Guidelines
Inclusion Terms
- Dana-Putnam syndrome
- Sclerosis of spinal cord (combined) (dorsolateral) (posterolateral)
Excludes Type 1
- syphilitic combined degeneration of spinal cord (A52.11)
Code First
- underlying disease, such as:
- other dietary vitamin B12 deficiency anemia (D51.3)
- vitamin B12 deficiency anemia due to intrinsic factor deficiency (D51.0)
- vitamin B12 deficiency anemia, unspecified (D51.8)
- vitamin B12 deficiency (E53.8)
Medical Intelligence & Overview
Subacute combined degeneration of the spinal cord is a condition that affects the nerves within the spinal cord, leading to neurological symptoms. It is often associated with deficiencies in vitamin B12 and can occur alongside other neurological disorders. This condition is classified under ICD-10 code G32.0 and sometimes referred to as Dana-Putnam syndrome or sclerosis of the spinal cord, dorsolateral or posterolateral. Recognizing the signs early and understanding its causes can aid in effective management.
Causes & Symptoms
Clinical Causes: Vitamin B12 deficiency: The primary cause is insufficient vitamin B12, which is essential for nerve health. Malabsorption syndromes: Conditions such as pernicious anemia, Crohn's disease, or celiac disease can impair vitamin B12 absorption. Dietary insufficiency: Lack of vitamin B12-rich foods, particularly in vegans or vegetarians without supplementation. Certain medications: Long-term use of drugs like metformin or proton pump inhibitors may interfere with B12 absorption. Surgical removal of parts of the stomach or intestines: These procedures can reduce B12 absorption. Neurological injuries or diseases: Some conditions can mimic or contribute to spinal cord degeneration.
Key Symptoms: Weakness and numbness in the legs and arms Loss of coordination and balance Sensory disturbances, such as tingling or burning sensations Difficulty walking or unsteady gait Muscle stiffness or spasticity Psychological changes, including memory loss or mood alterations Vision problems or abnormal eye movements in some cases
Diagnostic & Treatment
Diagnosis Path: Doctors diagnose subacute combined degeneration through a combination of clinical evaluation and laboratory tests. These include blood tests to check vitamin B12 levels, imaging studies like MRI to visualize the spinal cord, and nerve conduction studies to assess nerve function. Sometimes, a spinal fluid analysis is conducted to rule out infections or other neurological disorders. Recognizing characteristic symptoms alongside laboratory findings helps establish the diagnosis.
Treatment Protocols: Administering vitamin B12 injections, typically weekly at the start, then monthly for maintenance Addressing underlying causes of deficiency, such as managing malabsorption or dietary adjustments Physical therapy to help regain muscle strength and improve coordination Monitoring and follow-up to assess neurological improvement and prevent progression
Clinical Advice & FAQs
Billing Guidance
Is G32.0 a billable ICD-10 code?
Yes, G32.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G32.0?
Clinical documentation must specify the nature of Subacute combined degeneration of spinal cord in diseases classified elsewhere and any associated comorbidities for accurate reporting.
Cite this Clinical Reference